US Stem Cell Inc (USRM) Stock Price, Trades & News

US Stem Cell Inc is a biotechnology company engaged in the discovery and development of autologous cell therapies for the treatment of chronic and acute heart damage. Its product includes MyoCell, a clinical therapy designed to populate regions of scar tissue within a patient's heart with autologous muscle cells, or cells from a patient's body, for the purpose of improving cardiac function in chronic heart failure patients. The company's discoveries include multiple cell therapies in various stages of development that repair damaged tissues throughout the body due to injury or disease so that patients may return to a normal lifestyle.

Financial Strength

	Name	Current	Vs Industry		Vs History

Growth Rank

	Name	Current	Vs Industry		Vs History

Momentum Rank

	Name	Current	Vs Industry		Vs History

Liquidity Ratio

	Name	Current	Vs Industry		Vs History

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History

Profitability Rank

	Name	Current	Vs Industry		Vs History
	FCF Margin %	-371.95
	OCF Margin %	-371.95

GF Value Rank

2/10

	Name	Current	Vs Industry		Vs History
	FCF Yield %	-11000

GF Value™

USRM

Warning Signs

Warning! GuruFocus detected issues with USRM. Try a 7-Day Free Trial to check it out.

US Stem Cell Inc Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

US Stem Cell Inc Stock Events

Financials Calendars

	Event	Date	Price ($)
	0.001:1 Stock Split	2015-11-04	2.85 (+90.00%)

Show

Entries

Guru Commentaries on OTCPK:USRM

No articles.

Press Release

	Subject	Date
	Court Reports Favorable Judgment in California Stem Cell Case	2022-09-01
	Mark Borman Appointed Chairman of the Board of USRM	2022-03-09
	USRM to Focus on Animal Health and Lead Pet-Care Innovation	2021-10-18
	US Stem Cell Inc Reports Legal Appeal Results and Company Direction	2021-06-08
	Northstar Biotech and USRM BOD Members Reinvest in the Company	2021-02-23
	USRM Oral Argument in Appeal from FDA Enforcement Action	2021-01-19
	U.S. Stem Cell Confirms Date for Appeals Court Oral Arguments	2020-09-30
	Corrected: USRM Posts Earnings for Second Quarter 2019	2019-08-09
	USRM Posts Earnings for Second Quarter 2019	2019-08-07
	USRM Posts Financial Results for First Quarter 2019	2019-05-07

10/Page

Articles on US Stem Cell Inc

No articles.

Headlines

No news.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.